SUPPRELIN® LA Support Center

SUPPRELIN LA Support Center

For some families, out-of-pocket treatment costs may create undue financial or emotional strain. The                 SUPPRELIN LA Support Center provides free counseling to connect you with programs that may assist with the cost of copayments and deductibles. They can also work on your behalf to organize and coordinate the services needed to initiate SUPPRELIN LA.

Your SUPPRELIN LA Support Center representative provides confidential reimbursement services, including:

  • Verification of insurance coverage
  • Clarifying deductables and co-pay for treatment and for procedures
  • Assistance with general reimbursement questions
  • Coordination of the SUPPRELIN LA shipment directly to the procedure center identified by your doctor

The SUPPRELIN LA Support Center is available Monday-Friday from 8AM - 6PM EST toll-free at 1-855-270-0123 and ask for "SUPPRELIN LA Support Center".

Be sure to read the Support Center Brochure before calling as it is the first step to enrolling with the          SUPPRELIN LA Support Center.


 

 

 

Support Center Brochure

Get Adobe Reader

SUPPRELIN LA SHARES

The SUPPRELIN LA SHARES program offers extended payment terms for patient co-pay responsibilities. The SUPPRELIN LA SHARES program is available to patients where permissible by law.

Next: Doctor Discussion Guide

Indication

SUPPRELIN® LA (histrelin acetate) subcutaneous implant is used for the treatment of children with central precocious puberty (CPP).

Important Safety Information

  • SUPPRELIN LA should not be used by women who are or may become pregnant, and in patients who are allergic to gonadotropin releasing hormone (GnRH) or GnRH agonist analogs. Safety and effectiveness in children under 2 years of age has not been determined.

  • SUPPRELIN LA, like other GnRH agonists, may cause a temporary increase in the blood levels of specific hormones associated with the onset of puberty (estrogen in girls and testosterone in both sexes) during the first week of treatment. This increase may temporarily worsen puberty symptoms during the first week, additionally, you may see new symptoms appear during this period. Within the 4 weeks of treatment with SUPPRELIN LA, hormonal suppression generally occurs and the physical signs of puberty should decrease.

  • Your doctor should monitor the levels of specific hormones associated with puberty progression, 1 month after starting SUPPRELIN LA and then every 6 months thereafter. Every 6-12 months, height and bone age should be also monitored by your doctor.

  • During the clinical trial testing of SUPPRELIN LA, the most common side effects involved the implant site and included temporary bruising, pain, soreness, redness of the skin and swelling.

Please talk with your doctor for more information or if you have any questions.